J
Jonathan Wangisi
Researcher at The AIDS Support Organization
Publications - 18
Citations - 3556
Jonathan Wangisi is an academic researcher from The AIDS Support Organization. The author has contributed to research in topics: Pre-exposure prophylaxis & Population. The author has an hindex of 12, co-authored 18 publications receiving 3132 citations. Previous affiliations of Jonathan Wangisi include University of Washington & Centers for Disease Control and Prevention.
Papers
More filters
Journal ArticleDOI
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Jared M. Baeten,Deborah Donnell,Deborah Donnell,Patrick Ndase,Nelly Mugo,Nelly Mugo,James D. Campbell,Jonathan Wangisi,Jordan W. Tappero,Elizabeth A. Bukusi,Craig R. Cohen,Elly Katabira,Allan R. Ronald,Allan R. Ronald,Elioda Tumwesigye,Edwin Were,Kenneth H. Fife,James Kiarie,James Kiarie,Carey Farquhar,Grace John-Stewart,Aloysious Kakia,Josephine Odoyo,Akasiima Mucunguzi,Edith Nakku-Joloba,Rogers Twesigye,Kenneth Ngure,Cosmas Apaka,Harrison Tamooh,Fridah Gabona,Andrew Mujugira,Dana Panteleeff,Katherine K. Thomas,Lara Kidoguchi,Meighan Krows,Jennifer Revall,Susan Morrison,Harald S. Haugen,Mira Emmanuel-Ogier,Lisa Ondrejcek,Robert W. Coombs,Lisa M. Frenkel,Lisa M. Frenkel,Craig W. Hendrix,Namandjé N. Bumpus,David R. Bangsberg,Jessica E. Haberer,Wendy S. Stevens,Jairam R. Lingappa,Connie Celum +49 more
TL;DR: Oral TDF and TDF-FTC both protect against HIV-1 infection in heterosexual men and women, and both study medications significantly reduced the HIV- 1 incidence among both men andWomen.
Journal ArticleDOI
Adherence to Antiretroviral Prophylaxis for HIV Prevention: A Substudy Cohort within a Clinical Trial of Serodiscordant Couples in East Africa
Jessica E. Haberer,Jared M. Baeten,James D. Campbell,Jonathan Wangisi,Elly Katabira,Allan R. Ronald,Elioda Tumwesigye,Christina Psaros,Steven A. Safren,Norma C. Ware,Katherine K. Thomas,Deborah Donnell,Deborah Donnell,Meighan Krows,Lara Kidoguchi,Connie Celum,David R. Bangsberg,David R. Bangsberg +17 more
TL;DR: The association between high adherence to antiretroviral pre-exposure prophylaxis and HIV transmission in a substudy of serodiscordant couples participating in a clinical trial is investigated.
Journal ArticleDOI
Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial.
Nelly Mugo,Nelly Mugo,Nelly Mugo,Ting Hong,Connie Celum,Deborah Donnell,Deborah Donnell,Elizabeth A. Bukusi,Elizabeth A. Bukusi,Grace John-Stewart,Jonathan Wangisi,Edwin Were,Renee Heffron,Lynn T. Matthews,Susan Morrison,Kenneth Ngure,Jared M. Baeten +16 more
TL;DR: Differences in pregnancy incidence, birth outcomes, and infant growth were not statistically different for women receiving PrEP with TDF alone or combination FTC+TDF compared with placebo at conception, and definitive statements about the safety of PrEP in the periconception period cannot be made.
Journal ArticleDOI
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial
Jared M. Baeten,Deborah Donnell,Deborah Donnell,Nelly Mugo,Nelly Mugo,Patrick Ndase,Katherine K. Thomas,James D. Campbell,Jonathan Wangisi,Jordan W. Tappero,Elizabeth A. Bukusi,Craig R. Cohen,Elly Katabira,Allan R. Ronald,Allan R. Ronald,Elioda Tumwesigye,Edwin Were,Kenneth H. Fife,James Kiarie,James Kiarie,Carey Farquhar,Grace John-Stewart,Lara Kidoguchi,Robert W. Coombs,Craig W. Hendrix,Mark A. Marzinke,Lisa M. Frenkel,Lisa M. Frenkel,Jessica E. Haberer,David R. Bangsberg,Connie Celum +30 more
TL;DR: The results do not rule out the potential for a slight difference in HIV-1 protection with tenofovir disoproxil fumarate compared with emtricitabine plus ten ofovirdisioproxilfumarate, but show that once-daily oral tenofavir disOProxilFumarate or emticitabines plus tenofogel fumarine regimens both provide high protection against HIV- 1 acquisition in heterosexual men and women
Journal ArticleDOI
Characteristics of HIV-1 Serodiscordant Couples Enrolled in a Clinical Trial of Antiretroviral Pre-Exposure Prophylaxis for HIV-1 Prevention
Andrew Mujugira,Jared M. Baeten,Deborah Donnell,Deborah Donnell,Patrick Ndase,Nelly Mugo,Nelly Mugo,Linda E Barnes,James D. Campbell,Jonathan Wangisi,Jordan W. Tappero,Elizabeth A. Bukusi,Craig R. Cohen,Elly Katabira,Allan R. Ronald,Allan R. Ronald,Elioda Tumwesigye,Edwin Were,Kenneth H. Fife,James Kiarie,Carey Farquhar,Grace John-Stewart,Lara Kidoguchi,Dana Panteleeff,Meighan Krows,Heena Shah,Jennifer Revall,Susan Morrison,Lisa Ondrejcek,Charlotte Ingram,Robert W. Coombs,Jairam R. Lingappa,Connie Celum +32 more
TL;DR: Couples at high risk of HIV-1 transmission were rapidly recruited into the Partners PrEP Study, the largest efficacy trial of oral PrEP.